Broadening Clinical Trial Participation

Patient enrollment in clinical trials has long been on the minds of oncologists and researchers. In 1990, fewer than 3 percent of patients were enrolled in clinical trials—which spurred then president-elect of the American Cancer Society, Walter Lawrence Jr., MD, to write an editorial calling for more concerted efforts. More than 25 years later, clinical trial participation hovers around 5 percent.

Read More

Understanding Premalignancy and Cancer Risk

Prevention is often said to be more powerful than a cure. With an eye toward thwarting the disease, some researchers are trying to understand the molecular processes that are present in cells before cancer develops. These efforts, which analyze the potential power of premalignancy, are featured in the spring issue of Cancer Today.

Read More

Palliative Care: Putting a Cloak on Cancer

Hospice care and palliative care share similar goals in providing relief of pain and other symptoms, but they remain distinct: For cancer patients, hospice care can aid the terminally ill who have no treatment options, but palliative care can potentially improve quality of life for anyone with the disease, beginning at diagnosis.

Read More

New Guidelines Suggest Individualized Approach to Prostate Cancer Screening

The U.S. Preventive Services Task Force (USPSTF) released draft recommendations April 11 suggesting that doctors inform men ages 55 to 69 of the potential benefits and harms of prostate-specific antigen (PSA) blood testing to screen for prostate cancer. The draft says the decision to be screened is an individual one that should be made after consulting with a physician.

Read More